Cal-Maine to cull 1.8 million birds, halt production at Florida facility after bird flu detected

Cal-Maine Foods will cull 1.8 million birds and halt production at a Florida facility after detecting avian influenza. The cull includes 1.4 million laying hens and 360,000 pullets, representing 2.7% of its flock. The company is following USDA protocols. Bird flu has disrupted food supplies and driven up prices, though human infection risk is low, according to the CDC.

Original reporting
Published Nov 18, 2026, 2:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 18, 2026, 2:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cal-Maine to cull 1.8 million birds, halt production at Florida facility after bird flu detected — source image
Decision brief

The 30-second read

$CALMBearishMed
01

Why it matters

A confirmed HPAI detection triggers USDA protocol-driven production suspension and a defined cull, creating a tangible near-term supply shock for eggs from the affected facility.

02

Market read

Traders can reassess near-term egg supply tightness and producer-specific disruption risk based on the facility shutdown and cull magnitude.

03

What to watch

Market reaction may depend on how quickly USDA/CDC protocols allow restocking, whether additional sites are affected, and how egg futures and spot prices move relative to prior bird-flu expectations.

Relevance 7/10Novelty 7/10Timing: today, as the company announces the cull and production halt

Background

Highly pathogenic avian influenza has caused large-scale culling in recent years, disrupting food supplies and lifting prices, while CDC says general public human risk is low.

Company-level read

Ticker impact

$CALMBearishMedium confidence
Context

Cal-Maine Foods will cull about 1.8 million birds and temporarily halt production at a Florida facility after highly pathogenic avian influenza was detected.

Expected impact

Likely downside bias as traders price in temporary production loss and broader egg supply tightness risk.

Evidence & confidence

The article discloses a specific operational shutdown and cull size (2.7% of flock) tied to a confirmed HPAI detection, which can affect near-term output and sentiment even without financial guidance.

Market effects

Adds to ongoing bird-flu-driven supply disruption narrative for the US egg market, potentially supporting egg prices and pressuring producers’ near-term volumes.

Florida facility shutdown can tighten regional supply and increase logistics and replenishment costs until operations resume.

Primarily US-focused, but continued HPAI outbreaks can reinforce global protein supply and price volatility expectations.

Counterpoint

Because the cull is only 2.7% of Cal-Maine’s flock, the earnings impact may be limited if the company can quickly contain the outbreak and resume production.

Key entities

  • Cal-Maine Foods

    US egg producer announcing culling and a temporary production halt at a Florida facility after HPAI detection.

  • US Department of Agriculture (USDA)

    Sets protocols Cal-Maine is following during the production suspension and culling process.

  • Centers for Disease Control and Prevention (CDC)

    States human health risk to the general US public from HPAI is considered low.

Related articles

$CALMMed

Maybe There Was an Egg Cartel After All

Egg prices in the U.S. surged in 2022, initially attributed to bird flu. However, federal investigators allege that Cal-Maine, Hickman's, and Versova coordinated to artificially inflate prices through surplus bids. Prices rose 120% by December. Cal-Maine, a publicly traded company, cited the flu in its investor announcement. Antimonopoly group Farm Action questioned the price hikes, noting flock sizes didn't justify the increase.

$CALMMed

Cal-Maine Foods (CALM), Why Is It Back In Focus Today?

Cal-Maine Foods (CALM) reported a first-quarter net loss of $58.62M, down from a profit a year ago, with sales at $539.61M. The stock has declined 10.67% over 30 days and 21.94% over 90 days, but remains up 64.84% and 149.34% over three and five years. The company is expanding specialty egg and prepared foods offerings, aiming for higher margins. Analysts estimate a fair value of $68.33, with the stock currently trading at $66.67. Risks include avian influenza and oversupply pressures.

$CALMMedAI 8/10

Is Cal-Maine’s (CALM) Egg Slump Already Priced Into the Stock?

Cal-Maine Foods (CALM), the largest US egg producer, reported a weak Q1 FY2027 with net sales down 41.5% to $539.6M and a net loss of $58.6M. Specialty eggs and prepared foods, now 54.1% of sales, remained profitable. Retail demand for specialty eggs and exports rose, while supply may be tightening. Management is expanding prepared foods capacity. Conventional eggs, still dominant, saw a 59.5% sales drop due to price declines.